Medpace Holdings (MEDP) Ratios
Medpace Holdings Ratios
MX:MEDP's free cash flow for Q3 2026 was $196.44M. For the 2026 fiscal year, MX:MEDP's free cash flow was decreased by $-20.16M and operating cash flow was $216.60M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.74 | 0.93 | 0.64 | 0.42 | 1.24 |
| Quick Ratio | 0.74 | 0.93 | 0.64 | 0.42 | 1.24 |
| Cash Ratio | 0.37 | 0.61 | 0.27 | 0.04 | 0.83 |
| Solvency Ratio | 0.32 | 0.34 | 0.28 | 0.28 | 0.29 |
| Operating Cash Flow Ratio | 0.53 | 0.55 | 0.47 | 0.48 | 0.47 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 26.14 | 0.00 | 7.76 | 0.00 |
| Net Current Asset Value | $ -526.78M | $ -246.09M | $ -504.05M | $ -632.15M | $ -16.09M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.07 | 0.09 | 0.14 | 0.08 |
| Debt-to-Equity Ratio | 0.30 | 0.18 | 0.25 | 0.49 | 0.14 |
| Debt-to-Capital Ratio | 0.23 | 0.15 | 0.20 | 0.33 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 4.30 | 2.54 | 2.96 | 3.50 | 1.74 |
| Debt Service Coverage Ratio | 0.00 | 18.62 | 635.82 | 4.98 | 1902.19 |
| Interest Coverage Ratio | 0.00 | 0.00 | 690.22 | 95.94 | 1891.57 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 4.74 | 4.83 | 4.64 | 5.92 | 3.65 |
| Net Debt to EBITDA | -0.63 | -1.03 | -0.28 | 0.53 | -1.50 |
| Profitability Margins | |||||
| Gross Profit Margin | 30.06% | 31.12% | 27.81% | 29.62% | 28.73% |
| EBIT Margin | 21.44% | 22.57% | 17.86% | 19.09% | 17.39% |
| EBITDA Margin | 22.55% | 23.95% | 19.26% | 20.62% | 19.23% |
| Operating Profit Margin | 21.14% | 21.19% | 17.86% | 19.09% | 17.39% |
| Pretax Profit Margin | 21.44% | 22.57% | 17.80% | 19.37% | 17.67% |
| Net Profit Margin | 17.83% | 19.17% | 15.00% | 16.81% | 15.92% |
| Continuous Operations Profit Margin | 17.83% | 19.17% | 15.00% | 16.81% | 15.92% |
| Net Income Per EBT | 83.18% | 84.97% | 84.25% | 86.75% | 90.09% |
| EBT Per EBIT | 101.39% | 106.50% | 99.66% | 101.49% | 101.63% |
| Return on Assets (ROA) | 22.84% | 19.25% | 17.07% | 18.14% | 10.96% |
| Return on Equity (ROE) | 98.27% | 48.98% | 50.60% | 63.50% | 19.08% |
| Return on Capital Employed (ROCE) | 84.68% | 44.85% | 46.03% | 50.76% | 18.01% |
| Return on Invested Capital (ROIC) | 67.94% | 37.24% | 38.78% | 40.36% | 16.23% |
| Return on Tangible Assets | 35.25% | 28.80% | 29.50% | 37.63% | 19.02% |
| Earnings Yield | 2.78% | 3.93% | 3.00% | 3.57% | 2.33% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.29 | 7.11 | 6.32 | 5.76 | 6.13 |
| Payables Turnover | 62.88 | 44.66 | 42.72 | 31.07 | 31.71 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 10.17 | 8.36 | 7.11 | 5.87 | 5.13 |
| Asset Turnover | 1.28 | 1.00 | 1.14 | 1.08 | 0.69 |
| Working Capital Turnover Ratio | -11.78 | -10.37 | -4.71 | -8.70 | 13.66 |
| Cash Conversion Cycle | 52.20 | 43.13 | 49.21 | 51.60 | 48.06 |
| Days of Sales Outstanding | 58.00 | 51.30 | 57.75 | 63.35 | 59.57 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 5.80 | 8.17 | 8.54 | 11.75 | 11.51 |
| Operating Cycle | 58.00 | 51.30 | 57.75 | 63.35 | 59.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 24.73 | 19.67 | 14.11 | 11.98 | 7.34 |
| Free Cash Flow Per Share | 23.64 | 18.49 | 12.91 | 10.84 | 6.55 |
| Dividend Paid and CapEx Coverage Ratio | 22.75 | 16.66 | 11.83 | 10.52 | 9.31 |
| Capital Expenditure Coverage Ratio | 22.75 | 16.66 | 11.83 | 10.52 | 9.31 |
| Operating Cash Flow Coverage Ratio | 5.21 | 4.07 | 3.05 | 2.05 | 2.01 |
| Operating Cash Flow to Sales Ratio | 0.28 | 0.29 | 0.23 | 0.27 | 0.23 |
| Free Cash Flow Yield | 4.21% | 5.56% | 4.21% | 5.10% | 3.01% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 35.91 | 25.44 | 33.30 | 28.04 | 42.92 |
| Price-to-Sales (P/S) Ratio | 6.40 | 4.88 | 4.99 | 4.71 | 6.83 |
| Price-to-Book (P/B) Ratio | 35.29 | 12.46 | 16.85 | 17.80 | 8.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 23.76 | 17.97 | 23.74 | 19.59 | 33.20 |
| Price-to-Operating Cash Flow Ratio | 22.72 | 16.89 | 21.73 | 17.73 | 29.64 |
| Price-to-Earnings Growth (PEG) Ratio | 1.82 | 0.61 | 1.55 | 0.57 | 1.76 |
| Enterprise Value Multiple | 27.77 | 19.33 | 25.65 | 23.39 | 34.02 |
| Enterprise Value | 15.84B | 9.76B | 9.31B | 7.04B | 7.47B |
| EV to EBITDA | 27.77 | 19.33 | 25.65 | 23.39 | 34.02 |
| EV to Sales | 6.26 | 4.63 | 4.94 | 4.82 | 6.54 |
| EV to Free Cash Flow | 23.23 | 17.06 | 23.48 | 20.05 | 31.80 |
| EV to Operating Cash Flow | 22.21 | 16.04 | 21.49 | 18.14 | 28.39 |
| Tangible Book Value Per Share | -8.21 | 4.16 | -4.53 | -9.70 | 6.95 |
| Shareholders’ Equity Per Share | 15.91 | 26.67 | 18.19 | 11.93 | 26.57 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.17 | 0.15 | 0.16 | 0.13 | 0.10 |
| Revenue Per Share | 87.72 | 68.13 | 61.38 | 45.08 | 31.85 |
| Net Income Per Share | 15.64 | 13.06 | 9.21 | 7.58 | 5.07 |
| Tax Burden | 0.83 | 0.85 | 0.84 | 0.87 | 0.90 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.01 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.08 | 0.09 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.58 | 1.51 | 1.53 | 1.58 | 1.45 |
Currency in USD
